Topics:

Rheumatology Network

Five Reasons Your Patients Should Join Arthritis Power

A new symptom-tracking app isn't merely about helping your patients. It's about helping them help everyone with their condition by sharing their experience in a systematic way. Founder Jeffrey Curtis MD describes the new registry and its goals.

Recent Content

(CCR2015) The "Green Berets" of the brain, microglia cells, become hyperactive in fibromyalgia and are key to causing symptoms, said a psychologist and neuroscientist. Finding ways to control them is the key to future treatments, he feels.

(CCR2015) Nearly 100 new molecules are in development as RA treatments. This summary of a recent presentation by the ever-eloquent Ed Keystone MD gives a brief rundown of their mechanisms, progress, and potential.

Are you letting meaningless details squander your mental currency in rheumatology practice? The author points out how to recapture energy stolen by mere paperwork that should be used on your real job: Patient care.

osteoporosis

(CCR 2015) A number of new osteoporosis treatments are on the near horizon, drawing on a new understanding of bone biology, as described by a speaker at the Clinical Congress of Rheumatology.

rheumatoid arthritis

(CCR 2015) A new rheumatoid arthritis (RA) research center in the UK intends to revolutionize the understanding and treatment of the rheumatoid arthritis by 2020 by using systems biology to move beyond the one-molecule paradigm.

That smile on your patient’s face may conceal a great deal of pain that goes along with having lupus, much of which is not actually physical. Here, a patient in her early 30s describes how a lupus diagnosis changed almost everything.

rheumatoid arthritis

One very targeted clue to treatment failure: An observational study from Israel identifies Sephardic Jews as more likely than Ashkenazim to form antibodies against the biologic drug infliximab.

By clicking Accept, you agree to become a member of the UBM Medica Community.